This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Tyler, C. J. et al. Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitment and control of the microbiota during chronic colitis. Mucosal Immunol. https://doi.org/10.1038/s41385-021-00445-z (2021)
Becker, E. et al. Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Gut https://doi.org/10.1136/gutjnl-2021-324868 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotsiliti, E. Integrin-based therapy in IBD. Nat Rev Gastroenterol Hepatol 18, 747 (2021). https://doi.org/10.1038/s41575-021-00526-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-021-00526-1